New patent for Pharmacyclics Llc drug IMBRUVICABy DrugPatentWatch – Make Better Decisions / May 7, 2024 Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Llc and is included in three NDAs. It is available from one supplier. There are fifty-four patents…Source